Zoetis Inc. (NYSE: ZTS), the world’s largest animal health company, has announced a definitive agreement to acquire the global animal genomics business of Neogen Corporation (NASDAQ: NEOG), a strategic move designed to accelerate genomics-driven solutions across livestock and companion animal sectors.
Under the terms of the agreement, Zoetis will pay approximately $160 million for Neogen’s genomics business, subject to customary adjustments. The transaction is expected to close in the second half of 2026, pending regulatory approvals and standard closing conditions.
Neogen’s genomics unit operates through five laboratories in the United States, Brazil, Australia, China, and the United Kingdom, with a presence in Canada as well. The business provides advanced genotyping, sequencing, and data solutions that support data-driven breeding and management decisions across multiple livestock species. The platform has established strength in beef and dairy genomics, along with broader species applications.
According to Zoetis leadership, the acquisition strengthens its commitment to advancing animal health through innovation, data integration, and predictive technologies. The addition of Neogen’s genomics capabilities expands Zoetis’ Precision Animal Health portfolio, enhancing predictive insights and individualized care strategies for producers.
What This Means for Swine Producers
Genomics has increasingly become a cornerstone of modern herd management. Tools such as trait prediction, genetic selection platforms, and integrated data analytics are reshaping how producers approach long-term productivity, disease resilience, and sustainability goals.
For the swine sector specifically, enhanced genomic capabilities could support:
-
More precise breeding decisions
-
Improved disease resistance selection
-
Better alignment of genetics with nutrition and health protocols
-
Stronger performance benchmarking across systems
While the acquisition spans multiple species, its implications for pork production are significant. The integration of genomic data with animal health solutions reflects a broader industry movement toward precision livestock management, where genetics, health, nutrition, and performance data increasingly intersect.
Strategic Industry Context
This transaction reflects ongoing consolidation and focused investment within the animal genetics and precision health space. As margin pressures, sustainability goals, and biosecurity demands continue to intensify, producers are seeking tools that offer measurable, long-term value.
By bringing Neogen’s genomics business under its umbrella, Zoetis signals a deeper investment in data-enabled animal health platforms. The move aligns with a larger trend across the livestock industry: leveraging actionable data to drive performance, manage risk, and support more efficient production systems.
For swine producers and allied industry professionals, the evolution of genomics integration into animal health portfolios will be an area to watch closely as precision strategies continue to advance.
